About AbbVie
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
Finance Lead Planning and Analysis
The Finance Lead drives the financial planning and analysis processes and requirements across BTS Commercial Aesthetics. Ensures compliance with financial policies, prepares management analysis of actual vs. benchmark results, prepares financial analysis (Plan, LBEs, and LRP) and implements process improvements for areas of responsibility. Lead consolidation and submission of BTS HQ financial planning and analysis and deliverables to meet both BTS DHQ and Corporate FP&A; requirements.
Key Responsibilities Include:
* Leads and develops BTS Global Commercial Aesthetics monthly LBEs, Update, Plan, and LRP including P&L;, headcount and balance sheet using planning systems and incorporates review changes of both financial and operational management
* Prepare and understands Global Commercial Aesthetics monthly results and both prepares and reviews meaningful monthly management reporting packages
* Interact with all levels of management including BTS Commercial Aesthetics VPs, Directors, and Managers, BTS FP&A;, and Accounting COE
* Provides management with clear insights into drivers of business and financial performance and risk; assesses business/market opportunities and informs/recommends prioritization decisions
* Coordinate with Commercial Aesthetics FP&A; groups to develop models for New Product Launch and Plan/Update/LBE/LRP
* Consolidation of Business Technology Solutions (BTS) monthly LBEs, Update, Plan and LRP, including P&L;, headcount, balance sheet, expense and capital for Corporate FP&A; submission
* Consolidated monthly BTS Actual results, including variance analysis and commentary for P&L;, headcount and other BTS required matrix for Sr. BTS Leadership
* Prepares BTS Actual Monthly Report for AbbVie Corporate submission
* Leads ad hoc analysis, projects and process improvements as needed
Qualifications
Qualifications:
* Bachelors degree in Accounting or Finance. CPA or MBA a plus
* Minimum 8+ years progressive finance/ accounting experience
* Strong financial, analytical and problem solving skills
* Strong organizational and communication skills (verbal and written)
* Proficient excel skills required
* Knowledge of TM1, SAP and HFM is a plus
* Must be able to manage multiple priorities and adapt quickly to change to achieve required timeline
Key Leadership Competencies:
* Builds strong relationships with peers and cross functionally with partners outside of team to enable higher performance
* Learns and grasps concepts fast and can change course quickly where necessary
* Raises the bar and is never satisfied with the status quo
* Open to suggestions and experimentation for improvement
* Embraces the ideas of others, nurtures innovation and manages innovation to reality
* Anticipates problems and opportunities
* Has a great sense to prioritize responsibilities and lead project / processes
* Drives excellent performance without being close supervised
Significant Work Activities
Continuous sitting for prolonged periods (more than 2 consecutive hours in an 8 hour day)
Travel
Yes, 5 % of the Time
Job Type
Experienced
Schedule
Full-time
Job Level Code
IC
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.
Chicago, IL
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.
Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.